Transform the landscape of Rare Hemophilia by driving US HEOR strategy and execution. Collaborate cross-functionally to generate impactful evidence for market access, ensuring alignment with business goals and health economics best practices.

Elevate the US HEOR strategy for a Rare Hemophilia portfolio, driving cross-functional partnerships and ensuring robust evidence generation to support access and value demonstration in a rapidly evolving market landscape.

Advance the strategic direction and commercial performance of Heplisav B, leading cross-functional collaboration and driving measurable business results. This high-impact role demands strategic vision and accountability for execution and P&L performance.

Drive impactful research by applying functional genomics in advanced disease models. Collaborate with experts to validate targets and innovate techniques, merging science and technology to discover novel therapeutic avenues across multiple fields.

Drive innovation by leading scientific programming initiatives for pivotal clinical projects, ensuring high-quality data deliverables and compliance with regulatory standards, while managing cross-functional collaborations and vendor engagements.